FDA — authorised 17 April 1995
- Marketing authorisation holder: EUROHLTH INTL SARL
- Status: approved
🇺🇸 Revex in United States
FDA authorised Revex on 17 April 1995
Marketing authorisations
FDA — authorised 17 April 1995
- Application: NDA020459
- Marketing authorisation holder: HIKMA
- Local brand name: REVEX
- Indication: SOLUTION — INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
- Status: approved
Revex in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Revex approved in United States?
Yes. FDA authorised it on 17 April 1995; FDA authorised it on 17 April 1995.
Who is the marketing authorisation holder for Revex in United States?
EUROHLTH INTL SARL holds the US marketing authorisation.